D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 125 Citations 61,186 988 World Ranking 1236 National Ranking 744

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

His primary scientific interests are in Multiple myeloma, Internal medicine, Surgery, Gastroenterology and Bortezomib. His Multiple myeloma research includes themes of Monoclonal gammopathy of undetermined significance and Pathology. His work on Internal medicine is being expanded to include thematically relevant topics such as Oncology.

Surgery is often connected to Hematology in his work. His Gastroenterology study combines topics in areas such as Tolerability, Neutropenia, Hazard ratio, Myeloma protein and Survival analysis. His work is dedicated to discovering how Bortezomib, Cell growth are connected with Apoptosis and other disciplines.

His most cited work include:

  • Improved survival in multiple myeloma and the impact of novel therapies (1718 citations)
  • International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. (1706 citations)
  • Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma (833 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Multiple myeloma, Oncology, Surgery and Gastroenterology. Lenalidomide, Transplantation, Dexamethasone, Autologous stem-cell transplantation and Amyloidosis are the core of his Internal medicine study. His Lenalidomide study incorporates themes from Regimen and Neutropenia.

The various areas that Shaji Kumar examines in his Multiple myeloma study include Bone marrow, Cohort and Pathology. As a part of the same scientific family, Shaji Kumar mostly works in the field of Bone marrow, focusing on Cancer research and, on occasion, Apoptosis. His Oncology research is multidisciplinary, relying on both Newly diagnosed, Clinical trial, Immunology and Daratumumab.

He most often published in these fields:

  • Internal medicine (59.34%)
  • Multiple myeloma (57.20%)
  • Oncology (26.39%)

What were the highlights of his more recent work (between 2017-2021)?

  • Internal medicine (59.34%)
  • Multiple myeloma (57.20%)
  • Oncology (26.39%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Multiple myeloma, Oncology, Amyloidosis and Gastroenterology. His work on Transplantation, Lenalidomide, Dexamethasone and Autologous stem-cell transplantation as part of general Internal medicine research is frequently linked to In patient, thereby connecting diverse disciplines of science. His Multiple myeloma study integrates concerns from other disciplines, such as Newly diagnosed, Bone marrow and Cancer research.

His Oncology research is multidisciplinary, incorporating elements of Venetoclax, Hematopoietic stem cell transplantation, Clinical trial and MEDLINE. Shaji Kumar works mostly in the field of Amyloidosis, limiting it down to concerns involving AL amyloidosis and, occasionally, Retrospective cohort study. His work deals with themes such as Monoclonal gammopathy of undetermined significance, Cohort and Hazard ratio, which intersect with Gastroenterology.

Between 2017 and 2021, his most popular works were:

  • Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma. (282 citations)
  • Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance. (156 citations)
  • Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond (131 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

His primary areas of investigation include Internal medicine, Multiple myeloma, Oncology, Transplantation and Gastroenterology. His work often combines Internal medicine and In patient studies. His study in Multiple myeloma is interdisciplinary in nature, drawing from both Venetoclax and Clinical trial.

His studies in Transplantation integrate themes in fields like Maintenance therapy, Survival analysis and Stem cell. His Gastroenterology study also includes fields such as

  • Hazard ratio which intersects with area such as Surgery,
  • Hematopoietic stem cell transplantation that connect with fields like Melphalan. His biological study deals with issues like AL amyloidosis, which deal with fields such as Survival rate, Bone marrow and Retrospective cohort study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade.
Lancet Oncology (2014)

2775 Citations

Improved survival in multiple myeloma and the impact of novel therapies

Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy.
Blood (2008)

2418 Citations

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie.
Lancet Oncology (2016)

1131 Citations

Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

Jonathan J. Keats;Rafael Fonseca;Marta Chesi;Roelandt Schop.
Cancer Cell (2007)

1073 Citations

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz.
Leukemia (2014)

1058 Citations

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study

Ola Landgren;Robert A. Kyle;Ruth M. Pfeiffer;Jerry A. Katzmann.
Blood (2009)

1023 Citations

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Philippe Moreau;Tamás Masszi;Norbert Grzasko;Nizar J Bahlis.
The New England Journal of Medicine (2016)

844 Citations

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

S. K. Kumar;J. H. Lee;J. J. Lahuerta;G. Morgan.
Leukemia (2012)

833 Citations

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma.

S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy;Angela Dispenzieri.
Blood (2005)

806 Citations

Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy

Jens G. Lohr;Jens G. Lohr;Petar Stojanov;Petar Stojanov;Scott L. Carter;Peter Cruz-Gordillo.
Cancer Cell (2014)

796 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Shaji Kumar

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 345

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 332

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 328

Nikhil C. Munshi

Nikhil C. Munshi

Harvard University

Publications: 232

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 230

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 210

Ola Landgren

Ola Landgren

University of Miami

Publications: 206

Evangelos Terpos

Evangelos Terpos

National and Kapodistrian University of Athens

Publications: 194

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Publications: 194

Gareth J. Morgan

Gareth J. Morgan

New York University

Publications: 193

Sagar Lonial

Sagar Lonial

Emory University

Publications: 174

Pieter Sonneveld

Pieter Sonneveld

Erasmus University Rotterdam

Publications: 174

Maria-Victoria Mateos

Maria-Victoria Mateos

University of Salamanca

Publications: 160

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 160

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 155

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 154

Something went wrong. Please try again later.